Published in Neurology on November 01, 2013
How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care. Implement Sci (2016) 0.82
Neurology residency program as factor associated with thrombolysis utilization in acute stroke. Neurology (2013) 0.75
The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT. BMC Neurol (2015) 0.75
Is cirrhosis associated with lower odds of ischemic stroke: A nationwide analysis? World J Hepatol (2016) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med (2008) 28.42
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care (2005) 7.73
Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke (1998) 4.76
Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke (2005) 4.07
National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke (2008) 3.40
Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke (2009) 3.23
Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke (2004) 2.86
Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke (2011) 2.80
US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke (2009) 2.54
Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf (2008) 2.46
Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample. Neurology (2006) 2.29
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.11
Hospital volume and stroke outcome: does it matter? Neurology (2007) 2.07
The American Heart Association Get With The Guidelines program. Am Heart J (2004) 1.68
Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med (2007) 1.66
Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke (2011) 1.46
Incidence and characteristics of total stroke in the United States. BMC Neurol (2001) 1.37
Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc (2013) 1.22
Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke (2009) 1.18
International classification of diseases and current procedural terminology codes underestimated thrombolytic use for ischemic stroke. J Clin Epidemiol (2006) 1.09
tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology (2005) 1.05
Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke. J Stroke Cerebrovasc Dis (2011) 1.03
Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program. Circ Cardiovasc Qual Outcomes (2012) 1.00
The use and misuse of thrombolytic therapy within the Veterans Health Administration. Med Care (2012) 1.00
How diagnosis-related group 559 will change the US Medicare cost reimbursement ratio for stroke centers. Stroke (2007) 0.93
Thrombolysis and outcome of young stroke patients over the last decade: insights from the Nationwide Inpatient Sample. J Stroke Cerebrovasc Dis (2012) 0.86
Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010. Stroke (2012) 0.83
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation (2002) 2.71
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS (2011) 1.94
Streamlining of prehospital stroke management: the golden hour. Lancet Neurol (2013) 1.69
Microvascular brain pathology and late-life motor impairment. Neurology (2013) 1.64
Emotional neglect in childhood and cerebral infarction in older age. Neurology (2012) 1.50
Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke (2005) 1.48
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44
Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med (2004) 1.39
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke (2010) 1.35
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke (2010) 1.22
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
Postpartum eclampsia complicated by reversible cerebral herniation. Obstet Gynecol (2006) 1.15
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke (2013) 1.11
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke (2008) 1.11
A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis (2008) 1.11
Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke (2006) 1.10
Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke (2013) 1.08
Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis (2008) 1.07
Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med (2006) 1.06
Towards practical cognitive assessment for detection of early dementia: a 30-minute computerized battery discriminates as well as longer testing. Curr Alzheimer Res (2005) 1.01
Emergency physician and stroke specialist beliefs and expectations regarding telestroke. Stroke (2010) 1.00
Recognition and management of stroke in young adults and adolescents. Neurology (2013) 0.98
Computerized cognitive testing battery identifies mild cognitive impairment and mild dementia even in the presence of depressive symptoms. Am J Alzheimers Dis Other Demen (2006) 0.98
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous? Stroke (2004) 0.97
Telestroke 10 years later--'telestroke 2.0'. Cerebrovasc Dis (2009) 0.95
HIV and recent illicit drug use interact to affect verbal memory in women. J Acquir Immune Defic Syndr (2013) 0.95
Alteplase for ischaemic stroke--much sooner is much better. Lancet (2010) 0.94
Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women's Interagency HIV Study. AIDS Res Hum Retroviruses (2011) 0.92
Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause (2014) 0.91
Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. J Stroke Cerebrovasc Dis (2007) 0.90
Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med (2010) 0.90
The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women. J Neurol Sci (2011) 0.90
Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol (2004) 0.90
Stroke knowledge and barriers to stroke prevention among African Americans: implications for health communication. J Health Commun (2003) 0.88
Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. J Infect Dis (2012) 0.87
Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial. Cerebrovasc Dis (2013) 0.87
Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke (2009) 0.86
Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study. Neuroepidemiology (2002) 0.86
Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women's Interagency HIV Study (WIHS). J Neurovirol (2015) 0.85
Addressing racial and ethnic disparities in stroke: the time is now. Neurology (2006) 0.85
Mild stroke and rapidly improving symptoms: it's not always a happy ending. Stroke (2011) 0.85
The cost-effectiveness of primary stroke centers for acute stroke care. Stroke (2012) 0.84
Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke (2013) 0.84
Effectiveness of stroke education in the emergency department waiting room. J Stroke Cerebrovasc Dis (2010) 0.84
Factors related to the sensitivity of emergency medical service impression of stroke. Prehosp Emerg Care (2014) 0.83
Improved quality of stroke care for hospitalized Medicare beneficiaries in Michigan. Stroke (2005) 0.83
Capturing the scope of stroke: silent, whispering, and overt. Arch Neurol (2009) 0.82
Telemedicine for acute stroke: when virtual is as good as reality. Neurology (2007) 0.80
Acute injury to superficial cortex leads to a decrease in synaptic inhibition and increase in excitation in neocortical layer V pyramidal cells. J Neurophysiol (2006) 0.80
Clinical reasoning: an unusual lung mass causing focal weakness. Neurology (2012) 0.80
Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA? Neurology (2004) 0.80
Telestroke, QALYs, and current health care policy: the Heisenberg uncertainty principle. Neurology (2011) 0.79
HandiStroke: a handheld tool for the emergent evaluation of acute stroke patients. Acad Emerg Med (2003) 0.79
Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study. J Stroke Cerebrovasc Dis (2010) 0.79
Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in United States. Stroke (2013) 0.78
Is asymptomatic hemorrhagic transformation really innocuous? Neurology (2012) 0.78
Single-nucleotide polymorphisms in TrkB and risk for depression: findings from the women's interagency HIV study. J Acquir Immune Defic Syndr (2013) 0.78
Smoke without fire: the complex effects of cigarette smoking on thrombolytic therapy for acute ischemic stroke. Neurology (2005) 0.78
Vascular cognitive impairment: dementia biology and translational animal models. Curr Opin Investig Drugs (2009) 0.78
Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology (2012) 0.78
Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history. J Acquir Immune Defic Syndr (2013) 0.77
Lessons from adult stroke trials. Pediatr Neurol (2006) 0.77
The Continued Promise of Neuroprotection for Acute Stroke Treatment. J Exp Stroke Transl Med (2008) 0.77
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovasc Dis (2015) 0.77
HIV serostatus differs by catechol-O-methyltransferase Val158Met genotype. AIDS (2013) 0.76
Acute ischemic stroke in hospitalized medicare patients: evaluation and treatment. Stroke (2003) 0.76
Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail? J Neurol Sci (2004) 0.76
Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience. J Stroke Cerebrovasc Dis (2010) 0.76
Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey. J Stroke Cerebrovasc Dis (2007) 0.76
A web-based interactive database system for a transcranial Doppler ultrasound laboratory. J Neuroimaging (2006) 0.75
Safer thrombolysis for acute ischemic stroke: is early recanalization the key? Neurology (2008) 0.75
The Relationship between Tests of Neurocognition and Performance on a Laparoscopic Simulator. Minim Invasive Surg (2010) 0.75
A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke. Lancet Neurol (2010) 0.75
Reversible cerebral vasoconstriction syndrome: a rose by any other name? Arch Neurol (2011) 0.75
Thrombophilias and stroke: diagnosis, treatment, and prognosis. J Thromb Thrombolysis (2005) 0.75
Spontaneous cervical artery dissection: is there a gender innuendo? Neurology (2006) 0.75
The "almost magical" mobile stroke unit revolution. Neurology (2012) 0.75
Is telemedicine the answer for delivering stroke care to rural areas? Nat Clin Pract Neurol (2007) 0.75
The interplay of age, access to health care, and insurance status: the good, the bad, and the ugly. Arch Neurol (2007) 0.75
Potassium depletion as a risk factor for stroke: will a banana a day keep your stroke away? Neurology (2002) 0.75
The A's and B's of the ABC's of stroke mechanisms and recurrence in pediatric ischemic stroke. Neurology (2012) 0.75
Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies. J Exp Stroke Transl Med (2011) 0.75
aPL and stroke in young women: more fuel for the stroke risk fire. Stroke (2002) 0.75
The time man has cometh to brain: tick...death....tick...death. Stroke (2005) 0.75
Antiphospholipid antibodies: pinning risk on a moving target. Lancet Neurol (2009) 0.75
Patient page. Clot-busting therapy helps stroke victims--but only if they get treatment in time. Neurology (2005) 0.75
Hemorrhages from cerebral amyloid angiopathy. Am J Med Sci (2012) 0.75
The management of stroke in antiphospholipid syndrome. Curr Rheumatol Rep (2012) 0.75
Atherosclerotic Peripheral Vascular Disease Symposium II: stroke intervention: state of the art. Circulation (2008) 0.75
Detection of carotid stenosis in African Americans with ischemic heart disease. J Vasc Surg (2006) 0.75
Hospital surveillance of acute stroke treatment in Michigan. J Stroke Cerebrovasc Dis (2007) 0.75